arrow
E

Estefanía Nova-Lamperti

Universidad de Concepción
H指数:25
被引数:2,925

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CXCL9 and CXCL10 support the exacerbated humoral response in recovered COVID-19 patients who developed acute respiratory distress syndrome by promoting plasma cell differentiation; whereas CXCL9 also induces CD40L and CXCR3 upregulation on T helper cells

CXCL9和CXCL10通过促进浆细胞分化,支持在发展为急性呼吸窘迫综合征的康复COVID-19患者中加剧体液反应;而CXCL9也能诱导T辅助细胞上调CD40L和CXCR3。

2025-12-040
OAAI
Host-microbe computational proteomic landscape in oral cancer revealed key functional and metabolic pathways between Fusobacterium nucleatum and cancer progression

宿主-微生物计算蛋白质组学景观在口腔癌中揭示了福赛拟杆菌与癌症进展之间的关键功能和代谢通路

2025-01-022
OA
MicroRNA-guided drug discovery for mitigating persistent pulmonary complications in critical COVID-19 survivors: A longitudinal pilot study
2024-02-153
OAAI
Clinical and pulmonary function analysis in long-COVID revealed that long-term pulmonary dysfunction is associated with vascular inflammation pathways and metabolic syndrome

long-COVID的临床和肺功能分析显示,长期肺功能障碍与血管炎症途径和代谢综合征有关

2023-10-0612
OAAI
Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile

在智利使用CoronaVac (Sinovac) 和BNT162b2 (Pfizer/BioNTech) 疫苗的异源疫苗组引起的针对SARS-CoV-2的体液免疫

2023-08-243
OAAI
Analysis of the protumoral mechanisms of F.nucleatum on growth, epithelial-mesenchymal transition and the expression of immunosuppressive markers in cell line of OSCC
2023-05-010
OA
IFI27 transcription is an early predictor for COVID-19 outcomes, a multi-cohort observational study
2023-01-0537
OAAI